Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.

about

Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.

Item

http://www.wikidata.org/entity/Q42795549

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Activating Peripheral Innate I ...... ytic Virotherapy in the Brain.

@en

Activating Peripheral Innate I ...... ytic Virotherapy in the Brain.

@nl

type

Item

label

Activating Peripheral Innate I ...... ytic Virotherapy in the Brain.

@en

Activating Peripheral Innate I ...... ytic Virotherapy in the Brain.

@nl

prefLabel

Activating Peripheral Innate I ...... ytic Virotherapy in the Brain.

@en

Activating Peripheral Innate I ...... ytic Virotherapy in the Brain.

@nl

P1476

Activating Peripheral Innate I ...... ytic Virotherapy in the Brain.

@en

P2093

Beta Yadollahi

http://www.w3.org/2001/XMLSchema#string

Charles Lefebvre

http://www.w3.org/2001/XMLSchema#string

David F Stojdl

http://www.w3.org/2001/XMLSchema#string

Jan Brun

http://www.w3.org/2001/XMLSchema#string

Lukxmi Balathasan

http://www.w3.org/2001/XMLSchema#string

Melanie Labelle

http://www.w3.org/2001/XMLSchema#string

Stephanie L Swift

http://www.w3.org/2001/XMLSchema#string

Vera A Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.

Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models.

A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.

Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM

The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

Identification of genetically modified Maraba virus as an oncolytic rhabdovirus.

Distinct macrophage subpopulations regulate viral encephalitis but not viral clearance in the CNS

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.

P304

45-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTO.2017.09.004

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29062886

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5645178

http://www.w3.org/2001/XMLSchema#string